The timing and specificity of prenatal immune risk factors for autism modeled in the mouse and relevance to schizophrenia

NeuroSignals

Volumn 18, Issue 2, 2011, Pages 129-139

  McAlonan, Gráinne M ^a,b   Li, Qi ^a   Cheung, Charlton ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Autism; Infection; Inflammation; Mouse model; Pregnancy; Prenatal infection; Schizophrenia

Indexed keywords

BRAIN ANTIBODY; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; NEUROTRANSMITTER; POLYINOSINIC POLYCYTIDYLIC ACID;

AUTISM; BEHAVIOR; BRAIN MATURATION; COGNITION; EMOTION; ENVIRONMENTAL FACTOR; FACE VALIDITY; HEREDITY; HUMAN; IMMUNOREGULATION; INFECTION; INFLUENZA; INTERPERSONAL COMMUNICATION; MATERNAL DISEASE; MEDICAL LITERATURE; MOUSE; NERVE CELL DIFFERENTIATION; NEUROBIOLOGY; NONHUMAN; PHENOTYPE; POSTNATAL DEVELOPMENT; PRENATAL EXPOSURE; PROTEIN EXPRESSION; REVIEW; RISK ASSESSMENT; SCHIZOPHRENIA; SECOND TRIMESTER PREGNANCY; SOCIAL INTERACTION; SYSTEMATIC REVIEW;

ANIMALS; AUTISTIC DISORDER; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; IMMUNOLOGIC FACTORS; MALE; MICE; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RISK FACTORS; SCHIZOPHRENIA;

EID: 79952444133     PISSN: 1424862X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000321080     Document Type: Review

References (161)

1. Bailey A, Le Couteur A, Gottesman I, Bolton P, Simonoff E, Yuzda E, Rutter M: Autism as a strongly genetic disorder: evidence from a British twin study. Psychol Med 1995; 25: 63-77.
2. Gupta AR, State MW: Recent advances in the genetics of autism. Biol Psychiatry 2007; 61: 429-437. (Pubitemid 46185337)
3. Lamb JA, Moore J, Bailey A, Monaco AP: Autism: recent molecular genetic advances. Hum Mol Genet 2000; 9: 861-868. (Pubitemid 30216096)
4. Lamb JA, Parr JR, Bailey AJ, Monaco AP: Autism: in search of susceptibility genes. Neuromolecular Med 2002; 2: 11-28. (Pubitemid 37012507)
5. Monaco AP, Bailey AJ: Autism. The search for susceptibility genes. Lancet 2001; 358(Suppl):S3.
6. Ronald A, Happe F, Plomin R: Genetic research into autism. Science 2006; 311: 952, author reply 952.
7. Szatmari P, Jones MB, Zwaigenbaum L, MacLean JE: Genetics of autism: Overview and new directions. J Autism Dev Disord 1998; 28: 351-368.
8. Baron-Cohen S: The cognitive neuroscience of autism. J Neurol Neurosurg Psychiatry 2004; 75: 945-948.
9. Frith U, Happe F: Autism spectrum disorder. Curr Biol 2005; 15:R786-R790.
10. Bauman M, Kemper TL: Histoanatomic observations of the brain in early infantile autism. Neurology 1985; 35: 866-874. (Pubitemid 15025292)
11. Kemper TL, Bauman ML: Neuropathology of infantile autism. Mol Psychiatry 2002; 7(Suppl 2):S12-S13.
12. Brambilla P, Hardan A, di Nemi SU, Perez J, Soares JC, Barale F: Brain anatomy and development in autism: review of structural MRI studies. Brain Res Bull 2003; 61: 557-569. (Pubitemid 37163538)
13. Hallahan B, Daly EM, McAlonan G, Loth E, Toal F, O'Brien F, Robertson D, Hales S, Murphy C, Murphy KC, Murphy DG: Brain morphometry volume in autistic spectrum disorder: a magnetic resonance imaging study of adults. Psychol Med 2009; 39: 337-346.
14. McAlonan GM, Cheung C, Cheung V, Wong N, Suckling J, Chua SE: Differential effects on white-matter systems in high-functioning autism and Asperger's syndrome. Psychol Med 2009: 1-9.
15. McAlonan GM, Cheung V, Cheung C, Chua SE, Murphy DG, Suckling J, Tai KS, Yip LK, Leung P, Ho TP: Mapping brain structure in attention deficit-hyperactivity disorder: a voxel-based MRI study of regional grey and white matter volume. Psychiatry Res 2007; 154: 171-180. (Pubitemid 46275443)
16. McAlonan GM, Cheung V, Cheung C, Suckling J, Lam GY, Tai KS, Yip L, Murphy DG, Chua SE: Mapping the brain in autism. A voxel-based MRI study of volumetric differences and intercorrelations in autism. Brain 2005; 128: 268-276.
17. McAlonan GM, Daly E, Kumari V, Critchley HD, van Amelsvoort T, Suckling J, Simmons A, Sigmundsson T, Greenwood K, Russell A, Schmitz N, Happe F, Howlin P, Murphy DG: Brain anatomy and sensorimotor gating in Asperger's syndrome. Brain 2002; 125: 1594-1606. (Pubitemid 34755173)
18. McAlonan GM, Suckling J, Wong N, Cheung V, Lienenkaemper N, Cheung C, Chua SE: Distinct patterns of grey matter abnormality in high-functioning autism and Asperger's syndrome. J Child Psychol Psychiatry 2008; 49: 1287-1295.
19. Cheung C, Chua SE, Cheung V, Khong PL, Tai KS, Wong TKW, Ho TP, McAlonan GM: White matter fractional anisotrophy differences and correlates of diagnostic symptoms in autism. J Child Psychol Psychiatry 2009; 50: 1102-1112.
20. Brambilla P, Hardan AY, di Nemi SU, Caverzasi E, Soares JC, Perez J, Barale F: The functional neuroanatomy of autism. Funct Neurol 2004; 19: 9-17. (Pubitemid 38801579)
21. Just MA, Cherkassky VL, Keller TA, Kana RK, Minshew NJ: Functional and anatomical cortical underconnectivity in autism: evidence from an FMRI study of an executive function task and corpus callosum morphometry. Cereb Cortex 2007; 17: 951-961. (Pubitemid 46434636)
22. Just MA, Cherkassky VL, Keller TA, Minshew NJ: Cortical activation and synchronization during sentence comprehension in high-functioning autism: evidence of underconnectivity. Brain 2004; 127: 1811-1821. (Pubitemid 39061557)
23. Koshino H, Carpenter PA, Minshew NJ, Cherkassky VL, Keller TA, Just MA: Functional connectivity in an fMRI working memory task in high-functioning autism. Neuroimage 2005; 24: 810-821. (Pubitemid 40094563)
24. Critchley HD, Daly EM, Bullmore ET, Williams SC, Van Amelsvoort T, Robertson DM, Rowe A, Phillips M, McAlonan G, Howlin P, Murphy DG: The functional neuroanatomy of social behaviour: changes in cerebral blood flow when people with autistic disorder process facial expressions. Brain 2000; 123( Pt 11):2203-2212.
25. Arndt TL, Stodgell CJ, Rodier PM: The teratology of autism. Int J Dev Neurosci 2005; 23: 189-199. (Pubitemid 40313552)
26. Herbert MR, Russo JP, Yang S, Roohi J, Blaxill M, Kahler SG, Cremer L, Hatchwell E: Autism and environmental genomics. Neurotoxicology 2006; 27: 671-684. (Pubitemid 44232987)
27. Geier DA, Kern JK, Garver CR, Adams JB, Audhya T, Nataf R, Geier MR: Biomarkers of environmental toxicity and susceptibility in autism. J Neurol Sci 2009; 280: 101-108.
28. Kern JK, Jones AM: Evidence of toxicity, oxidative stress, and neuronal insult in autism. J Toxicol Environ Health B Crit Rev 2006; 9: 485-499. (Pubitemid 44715560)
29. Libbey JE, Sweeten TL, McMahon WM, Fujinami RS: Autistic disorder and viral infections. J Neurovirol 2005; 11: 1-10. (Pubitemid 40458366)
30. Ghaziuddin M: A family history study of Asperger syndrome. J Autism Dev Disord 2005; 35: 177-182.
31. Carroll LS, Owen MJ: Genetic overlap between autism, schizophrenia and bipolar disorder. Genome Med 2009; 1: 102.
32. Burbach JP, van der Zwaag B: Contact in the genetics of autism and schizophrenia. Trends Neurosci 2009; 32: 69-72.
33. Chan RC, Di X, McAlonan GM, Gong QY: Brain anatomical abnormalities in highrisk individuals, first-episode, and chronic schizophrenia: an activation likelihood estimation meta-analysis of illness progression. Schizophr Bull 2009, E-pub ahead of print.
34. Cheung C, Yu KK, Fung G, Leung MK, Wong C, Li Q, Sham PC, Chua SE, McAlonan GM: Autistic disorders and schizophrenia: related or remote? An anatomical likelihood estimation. PLoS ONE 2010, under revision.
35. Cheung V, Cheung C, McAlonan GM, Deng Y, Wong JG, Yip L, Tai KS, Khong PL, Sham P, Chua SE: A diffusion tensor imaging study of structural dysconnectivity in never-medicated, first-episode schizophrenia. Psychol Med 2008; 38: 877-885. (Pubitemid 351684593)
36. Chua SE, Cheung C, Cheung V, Tsang JT, Chen EY, Wong JC, Cheung JP, Yip L, Tai KS, Suckling J, McAlonan GM: Cerebral grey, white matter and CSF in never-medicated, first-episode schizophrenia. Schizophr Res 2007; 89: 12-21. (Pubitemid 44895585)
37. Chua SE, Deng Y, Chen EY, Law CW, Chiu CP, Cheung C, Wong JC, Lienenkaemper N, Cheung V, Suckling J, McAlonan GM: Early striatal hypertrophy in first-episode psychosis within 3 weeks of initiating antipsychotic drug treatment. Psychol Med 2009; 39: 793-800.
38. Leung M, Cheung C, Yu K, Yip B, Sham P, Li Q, Chua S, McAlonan G: Gray matter in first-episode schizophrenia before and after antipsychotic drug treatment. Anatomical likelihood estimation meta-analyses with sample size weighting. Schizophr Bulletin 2009, E-pub ahead of print.
39. Toal F, Bloemen OJ, Deeley Q, Tunstall N, Daly EM, Page L, Brammer MJ, Murphy KC, Murphy DG: Psychosis and autism: magnetic resonance imaging study of brain anatomy. Br J Psychiatry 2009; 194: 418-425.
40. Craig JS, Hatton C, Craig FB, Bentall RP: Persecutory beliefs, attributions and theory of mind: comparison of patients with paranoid delusions, Asperger's syndrome and healthy controls. Schizophr Res 2004; 69: 29-33. (Pubitemid 38625756)
41. Rausch JL, Sirota EL, Londino DL, Johnson ME, Carr BM, Bhatia R, Miller S: Open-label risperidone for Asperger's disorder: negative symptom spectrum response. J Clin Psychiatry 2005; 66: 1592-1597. (Pubitemid 43068701)
42. McDougle CJ, Stigler KA, Erickson CA, Posey DJ: Atypical antipsychotics in children and adolescents with autistic and other pervasive developmental disorders. J Clin Psychiatry 2008; 69(Suppl 4):15-20.
43. Posey DJ, Stigler KA, Erickson CA, McDougle CJ: Antipsychotics in the treatment of autism. J Clin Invest 2008; 118: 6-14.
44. Perry W, Minassian A, Lopez B, Maron L, Lincoln A: Sensorimotor gating deficits in adults with autism. Biol Psychiatry 2007; 61: 482-486. (Pubitemid 46185328)
45. Kumari V, Fannon D, Geyer MA, Premkumar P, Antonova E, Simmons A, Kuipers E: Cortical grey matter volume and sensorimotor gating in schizophrenia. Cortex 2008; 44: 1206-1214.
46. Braff DL, Geyer MA, Swerdlow NR: Human studies of prepulse inhibition of startle: Normal subjects, patient groups, and pharmacological studies. Psychopharmacology 2001; 156: 234-258. (Pubitemid 32705488)
47. Esterberg ML, Trotman HD, Brasfield JL, Compton MT, Walker EF: Childhood and current autistic features in adolescents with schizotypal personality disorder. Schizophr Res 2008; 104: 265-273.
48. van Os J, Kapur S: Schizophrenia. Lancet 2009; 374: 635-645.
49. Crespi B, Badcock C: Psychosis and autism as diametrical disorders of the social brain. Behav Brain Sci 2008; 31: 241-261, discussion 261-320.
50. Ornitz EM, Lane SJ, Sugiyama T, de Traversay J: Startle modulation studies in autism. J Autism Dev Disord 1993; 23: 619-637. (Pubitemid 24004289)
51. Swerdlow NR, Benbow CH, Zisook S, Geyer MA, Braff DL: A preliminary assessment of sensorimotor gating in patients with obsessive compulsive disorder. Biol Psychiatry 1993; 33: 298-301. (Pubitemid 23091509)
52. Light GA, Braff DL: Human and animal studies of schizophrenia-related gating deficits. Curr Psychiatry Rep 1999; 1: 31-40.
53. Swerdlow NR, Braff DL, Geyer MA: Animal models of deficient sensorimotor gating: What we know, what we think we know, and what we hope to know soon. Behav Pharmacol 2000; 11: 185-204. (Pubitemid 30449750)
54. Swerdlow NR, Braff DL, Taaid N, Geyer MA: Assessing the validity of an animal model of deficient sensorimotor gating in schizophrenic patients. Arch Gen Psychiatry 1994; 51: 139-154. (Pubitemid 24985903)
55. Swerdlow NR, Weber M, Qu Y, Light GA, Braff DL: Realistic expectations of pre-pulse inhibition in translational models for schizophrenia research. Psychopharmacology 2008; 199: 331-388.
56. Moy SS, Nadler JJ: Advances in behavioral genetics: mouse models of autism. Mol Psychiatry 2008; 13: 4-26. (Pubitemid 350275186)
57. Moy SS, Nadler JJ, Young NB, Perez A, Holloway LP, Barbaro RP, Barbaro JR, Wilson LM, Threadgill DW, Lauder JM, Magnuson TR, Crawley JN: Mouse behavioral tasks relevant to autism: phenotypes of 10 inbred strains. Behav Brain Res 2007; 176: 4-20. (Pubitemid 44879623)
58. Yerys BE, Wallace GL, Harrison B, Celano MJ, Giedd JN, Kenworthy LE: Set-shifting in children with autism spectrum disorders: reversal shifting deficits on the intradimensional/extradimensional shift test correlate with repetitive behaviors. Autism 2009; 13: 523-538.
59. Crider A: Perseveration in schizophrenia. Schizophr Bull 1997; 23: 63-74.
60. Lanser MG, Berger HJ, Ellenbroek BA, Cools AR, Zitman FG: Perseveration in schizophrenia: failure to generate a plan and relationship with the psychomotor poverty subsyndrome. Psychiatry Res 2002; 112: 13-26.
61. Brown AS: Prenatal infection as a risk factor for schizophrenia. Schizophr Bull 2006; 32: 200-202.
62. Brown AS, Begg MD, Gravenstein S, Schaefer CA, Wyatt RJ, Bresnahan M, Babulas VP, Susser ES: Serologic evidence of prenatal influenza in the etiology of schizophrenia. Arch Gen Psychiatry 2004; 61: 774-780. (Pubitemid 39031117)
63. Brown AS, Schaefer CA, Quesenberry CP Jr, Liu L, Babulas VP, Susser ES: Maternal exposure to toxoplasmosis and risk of schizophrenia in adult offspring. Am J Psychiatry 2005; 162: 767-773. (Pubitemid 40489141)
64. Chess S: Autism in children with congenital rubella. J Autism Child Schizophr 1971; 1: 33-47.
65. Chess S: Follow-up report on autism in congenital rubella. Journal of autism and childhood schizophrenia 1977; 7: 69-81.
66. Chess S, Fernandez P, Korn S: Behavioral consequences of congenital rubella. J Pediatr 1978; 93: 699-703. (Pubitemid 8389123)
67. Yamashita Y, Fujimoto C, Nakajima E, Isagai T, Matsuishi T: Possible association between congenital cytomegalovirus infection and autistic disorder. J Autism and Dev Disord 2003; 33: 455-459. (Pubitemid 37127942)
68. Ciaranello AL, Ciaranello RD: The neurobiology of infantile autism. Annu Rev Neurosci 1995; 18: 101-128.
69. Lipkin WI, Hornig M: Microbiology and immunology of autism spectrum disorders. Novartis Found Symp 2003; 251: 129-143, discussion 144-128, 281-197.
70. Fatemi SH, Cuadra AE, El-Fakahany EE, Sidwell RW, Thuras P: Prenatal viral infection causes alterations in nNOS expression in developing mouse brains. Neuroreport 2000; 11: 1493-1496. (Pubitemid 30365493)
71. Fatemi SH, Earle J, Kanodia R, Kist D, Emamian ES, Patterson PH, Shi L, Sidwell R: Prenatal viral infection leads to pyramidal cell atrophy and macrocephaly in adulthood: implications for genesis of autism and schizophrenia. Cell Mol Neurobiol 2002; 22: 25-33. (Pubitemid 34579406)
72. Hornig M, Briese T, Lipkin WI: Bornavirus tropism and targeted pathogenesis: virus-host interactions in a neurodevelopmental model. Adv Virus Res 2001; 56: 557-582. (Pubitemid 33804571)
73. Hornig M, Solbrig M, Horscroft N, Weissenbock H, Lipkin WI: Borna disease virus infection of adult and neonatal rats: models for neuropsychiatric disease. Curr Top Microbiol Immunol 2001; 253: 157-177. (Pubitemid 32416664)
74. Hornig M, Weissenbock H, Horscroft N, Lipkin WI: An infection-based model of neurodevelopmental damage. Proc Natl Acad Sci USA 1999; 96: 12102-12107. (Pubitemid 29502865)
75. Lancaster K, Dietz DM, Moran TH, Pletnikov MV: Abnormal social behaviors in young and adult rats neonatally infected with borna disease virus. Behav Brain Res 2007; 176: 141-148. (Pubitemid 44879620)
76. Shi L, Fatemi SH, Sidwell RW, Patterson PH: Maternal influenza infection causes marked behavioral and pharmacological changes in the offspring. J Neurosci 2003; 23: 297-302. (Pubitemid 36050430)
77. Shi L, Smith SE, Malkova N, Tse D, Su Y, Patterson PH: Activation of the maternal immune system alters cerebellar development in the offspring. Brain Behav Immun 2009; 23: 116-123.
78. Amaral DG, Schumann CM, Nordahl CW: Neuroanatomy of autism. Trends Neurosci 2008; 31: 137-145.
79. Maloku E, Covelo IR, Hanbauer I, Guidotti A, Kadriu B, Hu Q, Davis JM, Costa E: Lower number of cerebellar Purkinje neurons in psychosis is associated with reduced reelin expression. Proc Natl AcadSci USA 2010; 107: 4407-4411.
80. Fatemi SH, Emamian ES, Kist D, Sidwell RW, Nakajima K, Akhter P, Shier A, Sheikh S, Bailey K: Defective corticogenesis and reduction in reelin immunoreactivity in cortex and hippocampus of prenatally infected neonatal mice. Mol Psychiatry 1999; 4: 145-154. (Pubitemid 29163977)
81. Fatemi SH, Earle JA, McMenomy T: Reduction in reelin immunoreactivity in hippocampus of subjects with schizophrenia, bipolar disorder and major depression. Mol Psychiatry 2000; 5: 654-663, 571.
82. Fatemi SH, Snow AV, Stary JM, Araghi-Niknam M, Reutiman TJ, Lee S, Brooks AI, Pearce DA: Reelin signaling is impaired in autism. Biol Psychiatry 2005; 57: 777-787. (Pubitemid 40487922)
83. Fatemi SH, Stary JM, Egan EA: Reduced blood levels of reelin as a vulnerability factor in pathophysiology of autistic disorder. Cell Mol Neurobiol 2002; 22: 139-152.
84. Fatemi SH, Stary JM, Halt AR, Realmuto GR: Dysregulation of Reelin and Bcl-2 proteins in autistic cerebellum. J Autism Dev Disord 2001; 31: 529-535. (Pubitemid 37490147)
85. Guidotti A, Auta J, Davis JM, Di-Giorgi-Gerevini V, Dwivedi Y, Grayson DR, Impagnatiello F, Pandey G, Pesold C, Sharma R, Uzunov D, Costa E: Decrease in reelin and glutamic acid decarboxylase 67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study. Arch Gen Psychiatry 2000; 57: 1061-1069.
86. Fatemi SH, Pearce DA, Brooks AI, Sidwell RW: Prenatal viral infection in mouse causes differential expression of genes in brains of mouse progeny: a potential animal model for schizophrenia and autism. Synapse 2005; 57: 91-99. (Pubitemid 40911524)
87. Fatemi SH, Folsom TD, Reutiman TJ, Abu-Odeh D, Mori S, Huang H, Oishi K: Abnormal expression of myelination genes and alterations in white matter fractional anisotropy following prenatal viral influenza infection at E16 in mice. Schizophr Res 2009; 112: 46-53.
88. Li Q, Cheung C, Wei R, Hui ES, Feldon J, Meyer U, Chung S, Chua SE, Sham PC, Wu EX, McAlonan GM: Prenatal immune challenge is an environmental risk factor for brain and behavior change relevant to schizophrenia: evidence from MRI in a mouse model. PLoS ONE 2009; 4:e6354.
89. Meyer U, Engler A, Weber L, Schedlowski M, Feldon J: Preliminary evidence for a modulation of fetal dopaminergic development by maternal immune activation during pregnancy. Neuroscience 2008; 154: 701-709.
90. Meyer U, Feldon J, Schedlowski M, Yee BK: Immunological stress at the maternal-foetal interface: A link between neurodevelopment and adult psychopathology. Brain, behavior, and immunity 2006; 20: 378-388. (Pubitemid 43775782)
91. Meyer U, Feldon J, Schedlowski M, Yee BK: Towards an immuno-precipitated neurodevelopmental animal model of schizophrenia. Neurosci Biobehav Rev 2005; 29: 913-947. (Pubitemid 41097394)
92. Meyer U, Murray PJ, Urwyler A, Yee BK, Schedlowski M, Feldon J: Adult behavioral and pharmacological dysfunctions following disruption of the fetal brain balance between pro-inflammatory and IL-10-mediated anti-inflammatory signaling. Mol Psychiatry 2008; 13: 208-221.
93. Meyer U, Nyffeler M, Engler A, Urwyler A, Schedlowski M, Knuesel I, Yee BK, Feldon J: The time of prenatal immune challenge determines the specificity of inflammation-mediated brain and behavioral pathology. J Neurosci 2006; 26: 4752-4762. (Pubitemid 44315314)
94. Meyer U, Nyffeler M, Schwendener S, Knuesel I, Yee BK, Feldon J: Relative prenatal and postnatal maternal contributions to schizophrenia-related neurochemical dysfunction after in utero immune challenge. Neuropsychopharmacology 2008; 33: 441-456. (Pubitemid 350243354)
95. Meyer U, Nyffeler M, Yee BK, Knuesel I, Feldon J: Adult brain and behavioral pathological markers of prenatal immune challenge during early/middle and late fetal development in mice. Brain Behav Immun 2008; 22: 469-486. (Pubitemid 351451821)
96. Meyer U, Schwendener S, Feldon J, Yee BK: Prenatal and postnatal maternal contributions in the infection model of schizophrenia. Exp Brain Res 2006; 173: 243-257. (Pubitemid 44264888)
97. Meyer U, Yee BK, Feldon J: The neurodevelopmental impact of prenatal infections at different times of pregnancy: the earlier the worse? Neuroscientist 2007; 13: 241-256.
98. Nyffeler M, Meyer U, Yee BK, Feldon J, Knuesel I: Maternal immune activation during pregnancy increases limbic GABAA receptor immunoreactivity in the adult offspring: Implications for schizophrenia. Neuroscience 2006; 143: 51-62. (Pubitemid 44667305)
99. Makinodan M, Tatsumi K, Manabe T, Yamauchi T, Makinodan E, Matsuyoshi H, Shimoda S, Noriyama Y, Kishimoto T, Wanaka A: Maternal immune activation in mice delays myelination and axonal development in the hippocampus of the offspring. J Neurosci Res 2008; 86: 2190-2200.
100. Li Q, Cheung C, Wei R, Cheung V, Hui ES, You Y, Wong P, Chua SE, McAlonan GM, Wu EX: Voxel-based analysis of postnatal white matter microstructure in mice exposed to immune challenge in early or late pregnancy. Neuroimage 2010; 52: 1-8.
101. Smith SE, Li J, Garbett K, Mirnics K, Patterson PH: Maternal immune activation alters fetal brain development through interleukin-6. J Neurosci 2007; 27: 10695-10702. (Pubitemid 47535869)
102. Ponzio NM, Servatius R, Beck K, Marzouk A, Kreider T: Cytokine levels during pregnancy influence immunological profiles and neurobehavioral patterns of the offspring. Ann NY Acad Sci 2007; 1107: 118-128. (Pubitemid 47528788)
103. Hama T, Kushima Y, Miyamoto M, Kubota M, Takei N, Hatanaka H: Interleukin-6 improves the survival of mesencephalic catecholaminergic and septal cholinergic neurons from postnatal, two-week-old rats in cultures. Neuroscience 1991; 40: 445-452.
104. Hama T, Miyamoto M, Tsukui H, Nishio C, Hatanaka H: Interleukin-6 as a neurotrophic factor for promoting the survival of cultured basal forebrain cholinergic neurons from postnatal rats. Neurosci Lett 1989; 104: 340-344. (Pubitemid 19231157)
105. Pratt L, Ponzio NM, Ni L, Sheng I, Jonakait GM: Fetal microglia become activated following maternal immune challenge. IMFAR 2010.
106. Vuillermot S, Weber L, Feldon J, Meyer U: A longitudinal examination of the neurodevelopmental impact of prenatal immune activation in mice reveals primary defects in dopaminergic development relevant to schizophrenia. J Neurosci 2010; 30: 1270-1287.
107. Ulfig N, Friese K: Interleukin-6 receptor is highly expressed in the ganglionic eminence of the human fetal brain. Biol Neonate 1999; 76: 320-324. (Pubitemid 29473713)
108. Ulfig N: Ganglionic eminence of the human fetal brain - new vistas. Anat Rec 2002; 267: 191-195.
109. Beltinger C, Saule H: Sonography of subependymal cysts in congenital rubella syndrome. Eur J Pediatr 1988; 148: 206-207. (Pubitemid 19016138)
110. Borrell J, Vela JM, Arevalo-Martin A, Molina-Holgado E, Guaza C: Prenatal immune challenge disrupts sensorimotor gating in adult rats. Implications for the etiopathogenesis of schizophrenia. Neuropsychopharmacology 2002; 26: 204-215.
111. Fortier ME, Luheshi GN, Boksa P: Effects of prenatal infection on prepulse inhibition in the rat depend on the nature of the infectious agent and the stage of pregnancy. Behav Brain Res 2007; 181: 270-277. (Pubitemid 46898665)
112. Golan HM, Lev V, Hallak M, Sorokin Y, Huleihel M: Specific neurodevelopmental damage in mice offspring following maternal inflammation during pregnancy. Neuropharmacology 2005; 48: 903-917. (Pubitemid 40489045)
113. Fidel PL Jr, Romero R, Wolf N, Cutright J, Ramirez M, Araneda H, Cotton DB: Systemic and local cytokine profiles in endotoxin-induced preterm parturition in mice. Am J Obstet Gynecol 1994; 170: 1467-1475. (Pubitemid 24188728)
114. Molloy CA, Morrow AL, Meinzen-Derr J, Schleifer K, Dienger K, Manning-Courtney P, Altaye M, Wills-Karp M: Elevated cytokine levels in children with autism spectrum disorder. J Neuroimmunology 2006; 172: 198-205. (Pubitemid 43277506)
115. Gupta S, Aggarwal S, Rashanravan B, Lee T: Th1- and Th2-like cytokines in CD4+ and CD8+ T cells in autism. J Neuroimmunol 1998; 85: 106-109. (Pubitemid 28255444)
116. Pardo CA, Vargas DL, Zimmerman AW: Immunity, neuroglia and neuroinflammation in autism. Int Rev Psychiatry 2005; 17: 485-495. (Pubitemid 43086675)
117. Vargas DL, Nascimbene C, Krishnan C, Zimmerman AW, Pardo CA: Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann Neurol 2005; 57: 67-81. (Pubitemid 40053317)
118. Martin LA, Ashwood P, Braunschweig D, Cabanlit M, Van de Water J, Amaral DG: Stereotypies and hyperactivity in rhesus monkeys exposed to IgG from mothers of children with autism. Brain Behav Immun 2008; 22: 806-816.
119. Zimmerman AW, Connors SL, Matteson KJ, Lee LC, Singer HS, Castaneda JA, Pearce DA: Maternal antibrain antibodies in autism. Brain Behav Immun 2007; 21: 351-357. (Pubitemid 46199109)
120. Singer HS, Morris C, Gause C, Pollard M, Zimmerman AW, Pletnikov M: Prenatal exposure to antibodies from mothers of children with autism produces neurobehavioral alterations: a pregnant dam mouse model. J Neuroimmunol 2009; 211: 39-48.
121. Creasy RK, Resnik R, Iams JD, Lockwood CJ, Moore TR (eds): Creasy and Resnik's Maternal-Fetal Medicine: Principles and Practice, ed 6. Saunders/Elsevier Health Sciences 2004, pp 583-584.
122. Monji A, Kato T, Kanba S: Cytokines and schizophrenia: microglia hypothesis of schizophrenia. Psychiatry Clin Neurosci 2009; 63: 257-265.
123. Oppenheim SM, Moyer AL, BonDurant RH, Rowe JD, Anderson GB: Fetal leukocyte trafficking as a stimulus for the production of maternal antibodies in the goat. Theriogenology 2001; 55: 1583-1591. (Pubitemid 32423679)
124. Goodman HS, Masaitis L: Analysis of the isoimmune response to leucocytes: I. Maternal cytotoxic response to fetal lymphocytes. Proc Soc Exp Biol Med 1967; 126: 599-604.
125. O'Callaghan E, Sham P, Takei N, Glover G, Murray RM: Schizophrenia after prenatal exposure to 1957 A2 influenza epidemic. Lancet 1991; 337: 1248-1250.
126. Kunugi H, Nanko S, Takei N, Saito K, Hayashi N, Kazamatsuri H: Schizophrenia following in utero exposure to the 1957 influenza epidemics in Japan. Am J Psychiatry 1995; 152: 450-452.
127. Mednick SA, Huttunen MO, Machon RA: Prenatal influenza infections and adult schizophrenia. Schizophr Bull 1994; 20: 263-267. (Pubitemid 24171089)
128. Adams W, Kendell RE, Hare EH, Munk-Jorgensen P: Epidemiological evidence that maternal influenza contributes to the aetiology of schizophrenia. An analysis of Scottish, English, and Danish data. Br J Psychiatry 1993; 163: 522-534. (Pubitemid 23297472)
129. Bauman ML, Kemper TL: Neuroanatomic observations of the brain in autism: a review and future directions. Int J Dev Neurosci 2005; 23: 183-187. (Pubitemid 40313551)
130. Bailey A, Luthert P, Dean A, Harding B, Janota I, Montgomery M, Rutter M, Lantos P: A clinicopathological study of autism. Brain 1998; 121: 889-905. (Pubitemid 28220896)
131. Beversdorf DQ, Manning SE, Hillier A, Anderson SL, Nordgren RE, Walters SE, Nagaraja HN, Cooley WC, Gaelic SE, Bauman ML: Timing of prenatal stressors and autism. J Autism Dev Disord 2005; 35: 471-478. (Pubitemid 41216433)
132. Kinney DK, Miller AM, Crowley DJ, Huang E, Gerber E: Autism prevalence following prenatal exposure to hurricanes and tropical storms in Louisiana. J Autism Dev Disord 2008; 38: 481-488. (Pubitemid 351322368)
133. Atladottir HO, Thorsen P, Ostergaard L, Schendel DE, Lemcke S, Abdallah M, Parner ET: Maternal infection requiring hospitalization during pregnancy and autism spectrum disorders. J Autism Dev Disord 2010, E-pub ahead of print.
134. Clancy B, Darlington RB, Finlay BL: Translating developmental time across mammalian species. Neuroscience 2001; 105: 7-17. (Pubitemid 32722089)
135. Clancy B, Kersh B, Hyde J, Darlington RB, Anand KJ, Finlay BL: Web-based method for translating neurodevelopment from laboratory species to humans. Neuroinformatics 2007; 5: 79-94. (Pubitemid 46586614)
136. Swerdlow NR, Braff DL, Hartston H, Perry W, Geyer MA: Latent inhibition in schizophrenia. Schizophr Res 1996; 20: 91-103. (Pubitemid 26387507)
137. Geyer MA, Krebs-Thomson K, Braff DL, Swerdlow NR: Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review. Psychopharmacology 2001; 156: 117-154. (Pubitemid 32702206)
138. Nakamura K, Sekine Y, Ouchi Y, Tsujii M, Yoshikawa E, Futatsubashi M, Tsuchiya KJ, Sugihara G, Iwata Y, Suzuki K, Matsuzaki H, Suda S, Sugiyama T, Takei N, Mori N: Brain serotonin and dopamine transporter bindings in adults with high-functioning autism. Arch Gen Psychiatry 2010; 67: 59-68.
139. Nieminen-von Wendt T, Metsahonkala L, Kulomaki TA, Aalto S, Autti TH, Vanhala R, Eskola O, Bergman J, Hietala JA, Von Wendt LO: Increased presynaptic dopamine function in Asperger syndrome. Neuroreport 2004; 15: 757-760. (Pubitemid 38453452)
140. Hus V, Pickles A, Cook EH Jr, Risi S, Lord C: Using the autism diagnostic interview - revised to increase phenotypic homogeneity in genetic studies of autism. Biol Psychiatry 2007; 61: 438-448. (Pubitemid 46185341)
141. Fatemi SH, Reutiman TJ, Folsom TD, Huang H, Oishi K, Mori S, Smee DF, Pearce DA, Winter C, Sohr R, Juckel G: Maternal infection leads to abnormal gene regulation and brain atrophy in mouse offspring: implications for genesis of neurodevelopmental disorders. Schizophr Res 2008; 99: 56-70.
142. Fatemi SH, Emamian ES, Sidwell RW, Kist DA, Stary JM, Earle JA, Thuras P: Human influenza viral infection in utero alters glial fibrillary acidic protein immunoreactivity in the developing brains of neonatal mice. Mol Psychiatry 2002; 7: 633-640.
143. Fatemi SH, Reutiman TJ, Folsom TD, Sidwell RW: The role of cerebellar genes in pathology of autism and schizophrenia. Cerebellum 2008; 7: 279-294.
144. Sanjuan J, Tolosa A, Gonzalez JC, Aguilar EJ, Perez-Tur J, Najera C, Molto MD, de Frutos R: Association between FOXP2 polymorphisms and schizophrenia with auditory hallucinations. Psychiatr Genet 2006; 16: 67-72. (Pubitemid 44481207)
145. Gong X, Jia M, Ruan Y, Shuang M, Liu J, Wu S, Guo Y, Yang J, Ling Y, Yang X, Zhang D: Association between the FOXP2 gene and autistic disorder in Chinese population. Am J Med Genet B Neuropsychiatr Genet 2004; 127B:113-116. (Pubitemid 38542325)
146. Chua SE, McKenna PJ: Schizophrenia - a brain disease? A critical review of structural and functional cerebral abnormality in the disorder. Br J Psychiatry 1995; 166: 563-582.
147. Chua SE, Lam IW, Tai KS, Cheung C, Tang WN, Chen EY, Lee PW, Chan FL, Lieh-Mak F, McKenna PJ: Brain morphological abnormality in schizophrenia is independent of country of origin. Acta Psychiatr Scand 2003; 108: 269-275. (Pubitemid 37175901)
148. Vidal CN, Nicolson R, Boire JY, Barra V, DeVito TJ, Hayashi KM, Geaga JA, Drost DJ, Williamson PC, Rajakumar N, Toga AW, Thompson PM: Three-dimensional mapping of the lateral ventricles in autism. Psychiatry Res 2008; 163: 106-115.
149. Winter C, Reutiman TJ, Folsom TD, Sohr R, Wolf RJ, Juckel G, Fatemi SH: Dopamine and serotonin levels following prenatal viral infection in mouse - implications for psychiatric disorders such as schizophrenia and autism. Eur Neuropsychopharmacol 2008; 18: 712-716.
150. Perry W, Minassian A, Henry B, Kincaid M, Young JW, Geyer MA: Quantifying overactivity in bipolar and schizophrenia patients in a human open field paradigm. Psychiatry Res 2010; 178: 84-91.
151. Pierce K, Courchesne E: Evidence for a cerebellar role in reduced exploration and stereotyped behavior in autism. Biol Psychiatry 2001; 49: 655-664. (Pubitemid 32328116)
152. Walter H, Ciaramidaro A, Adenzato M, Vasic N, Ardito RB, Erk S, Bara BG: Dysfunction of the social brain in schizophrenia is modulated by intention type: an fMRI study. Soc Cogn Affect Neurosci 2009; 4: 166-176.
153. Williams DL, Goldstein G, Carpenter PA, Minshew NJ: Verbal and spatial working memory in autism. J Autism Dev Disord 2005; 35: 747-756.
154. Snyder PJ, Jackson CE, Piskulic D, Olver J, Norman T, Maruff P: Spatial working memory and problem solving in schizophrenia: the effect of symptom stabilization with atypical antipsychotic medication. Psychiatry Res 2008; 160: 316-326.
155. Feldon J, Weiner I: From an animal model of an attentional deficit towards new insights into the pathophysiology of schizophrenia. J Psychiatr Res 1992; 26: 345-366. (Pubitemid 23048827)
156. Bitanihirwe BK, Peleg-Raibstein D, Mouttet F, Feldon J, Meyer U: Late prenatal immune activation in mice leads to behavioral and neurochemical abnormalities relevant to the negative symptoms of schizophrenia. Neuropsychopharmacology 2010, E-pub ahead of print.
157. Gruzelier J, Thornton S, Staniforth D, Zaki S, Yorkston N: Active and passive avoidance learning in controls and schizophrenic patients on racemic propranolol and neuroleptics. Br J Psychiatry 1980; 137: 131-137. (Pubitemid 10034883)
158. Deng MY, McAlonan GM, Cheung C, Chiu CP, Law CW, Cheung V, Sham PC, Chen EY, Chua SE: A naturalistic study of grey matter volume increase after early treatment in anti-psychotic naive, newly diagnosed schizophrenia. Psychopharmacology 2009; 206: 437-446.
159. Honer WG, Falkai P, Chen C, Arango V, Mann JJ, Dwork AJ: Synaptic and plasticity-associated proteins in anterior frontal cortex in severe mental illness. Neuroscience 1999; 91: 1247-1255. (Pubitemid 29234254)
160. Davis KL, Stewart DG, Friedman JI, Buchsbaum M, Harvey PD, Hof PR, Buxbaum J, Haroutunian V: White matter changes in schizophrenia: evidence for myelin-related dysfunction. Arch Gen Psychiatry 2003; 60: 443-456. (Pubitemid 36539053)
161. Singh VK, Warren RP, Odell JD, Warren WL, Cole P: Antibodies to myelin basic protein in children with autistic behavior. Brain Behav Immun 1993; 7: 97-103. (Pubitemid 23227066)